BEN MAIMON CAROL 4
4 · BARR PHARMACEUTICALS INC · Filed Aug 28, 2006
Insider Transaction Report
Form 4
BEN MAIMON CAROL
DirectorPresident & COO Barr Res
Transactions
- Sale
Common Stock
2006-08-24$59.00/sh−2,300$135,700→ 14,377 total - Exercise/Conversion
Stock Appreciation Rights
2006-08-24−20,000→ 0 totalExercise: $46.99From: 2006-07-27Exp: 2015-07-27→ Common Stock (2,356 underlying) - Exercise/Conversion
Common Stock
2006-08-24$58.35/sh+2,356$137,484→ 16,677 total